by Mrudula Kulkarni

5 minutes

Inside the Pharma Manufacturing IT Summit, Ahmedabad: Why the Factory Floor Finally Gets a Seat at the Table

Inside PMITS Ahmedabad, 7 July 2026. 130 delegates, India's top pharma manufacturing IT leaders, on MES, CSA, GAMP 5, and the paperless transition.

Inside the Pharma Manufacturing IT Summit, Ahmedabad: Why the Factory Floor Finally Gets a Seat at the Table

Gujarat manufactures roughly a third of India's pharma output, and most of it is still validated the way it was in 2018. That gap — between what Gujarat's plants produce and how digitally mature their manufacturing IT actually is — is exactly what the Pharma Manufacturing IT Summit (PMITS) is built to confront, on 7 July 2026 at Le Méridien, Ahmedabad.


Why Ahmedabad, Specifically

This isn't an arbitrary city choice. Zydus, Torrent, Cadila, Alembic, and a dense cluster of API and formulation manufacturers sit in or around Ahmedabad and Gujarat more broadly. Twelve of India's top-20 pharma manufacturers run at least one Gujarat plant — the decision-makers who own validation budgets, MES rollouts, and digital plant strategy are already here, which matters more in manufacturing IT than in almost any other pharma technology category.


Who's in the Room

A pie chart showing the PMITS 130-delegate audience breakdown, highlighting a 70% majority of end-users like Manufacturing IT and CSV Heads.

PMITS is capped at 130 delegates with end-users guaranteed to dominate the room: Heads of Manufacturing IT (25%), CSV/Validation Heads (18%), Lab Informatics/LIMS Heads (15%), Plant IT/Site IT Managers (14%), QA Digital/Data Integrity leaders (12%), CIOs/CTOs (10%), and Serialisation/Track-and-Trace specialists (6%) — with 70%+ end-users and a deliberate minority of vendors.


Confirmed Speakers

Vikram Shukla (President, Zydus) delivers the Chief Guest address. The bench also includes Pramod Gokhale (Sr. President & Global CIO, Mankind Pharma), Dr. Bijender Mishra (Global IT Head & CISO, Alkem Laboratories), Ravi Kalla (CIO, Anthem Biosciences), Narinder Sagar (CIO, Corona Remedies), Rahul Songire (Sr. VP – Central Quality, Zydus Lifesciences), and Shyam Khante (former Director, GSK) — practitioners running the systems they speak about, not vendors presenting case studies of their own products.


The Agenda — Three Acts

  1. Act I — The Reset (09:00–13:30): Keynote — 'The MES Graveyard: why 7 of 10 Indian pharma MES projects die in year 2' · Panel — a real CSA conversation with Sun Pharma, Serum, Anthem & Corona Remedies
  2. Act II — The Floor (13:30–15:30): Curated seated lunch · 'What 300 pharma sites taught us about AI' · Fireside chat with Shyam Khante — 'From Shopfloors to Boardrooms'
  3. Act III — The Build (15:30–18:30): Panel — 'What if ransomware hit your plant tomorrow?' with Alkem, Akums & ex-CISO Lupin · 'How we cleared a USFDA 483 — a QA-IT joint war room' · Closed Leadership Roundtable on the 5-year manufacturing IT investment map


Know More about Agenda here Read More


What Delegates Leave With

A checklist graphic outlining five key PMITS event takeaways, including a 2030 IT Blueprint, a CSV to CSA playbook, and GAMP 5 readiness.

  1. A Manufacturing IT 2030 Blueprint for the next plant investment review
  2. A CSV → CSA Migration Playbook — what to retire, retain, and defend in an inspection
  3. A GAMP 5 Ed.2 & Annex 22 Readiness Checklist for AI-in-GMP and paperless batch records
  4. Unfiltered, Chatham House peer intelligence on real MES, LIMS, and Digital Twin deployments
  5. 12 months of Pharma Now manufacturing IT intelligence post-event


The Bigger Picture

PMITS sits inside the broader CSV-to-CSA transition, GAMP 5 Ed.2 adoption curve, and MES/LIMS modernisation wave reshaping pharma manufacturing IT across India — the themes covered across this series. For Indian pharma manufacturing IT leaders, Ahmedabad on 7 July is where those shifts stop being regulatory bulletins and become a room full of people who actually have to execute them.

EARLY BIRD CLOSES 18 JUNE 2026 | Executive Pass: ₹4,990 + GST | 130 Seats, Reviewed Applications

Reserve your seat

Author Profile

Mrudula Kulkarni

Managing Editor - Pharma Now

Comment your thoughts

Author Profile

Mrudula Kulkarni

Managing Editor - Pharma Now

Ad
Advertisement

You may also like

Article
Compliance In Pharma Manufacturing 2025: Key Regulations And Best Practices You Need to Know

Enoch Daniel